More about

Heparin

News
April 17, 2023
2 min read
Save

CAD does not increase short-term risk, major bleeding after TAVR

CAD does not increase short-term risk, major bleeding after TAVR

Patients with CAD were no more likely to experience major bleeding or adverse CV events after transcatheter aortic valve replacement compared with patients without CAD, according to a post hoc analysis of data from the BRAVO-3 study.

News
November 09, 2022
2 min read
Save

BRIGHT-4: Bivalirudin bests heparin in STEMI PCI with radial access

BRIGHT-4: Bivalirudin bests heparin in STEMI PCI with radial access

CHICAGO — In patients with STEMI undergoing primary PCI, mostly with radial artery access, anticoagulation with bivalirudin reduced death and major bleeding at 30 days compared with heparin, according to the results of the BRIGHT-4 trial.

News
October 21, 2022
1 min read
Save

LOW RAO

LOW RAO

Anticoagulation with low-molecular-weight heparin vs. no treatment for radial artery occlusion.

News
July 27, 2022
2 min read
Save

Patients with history of skin reactions to heparin tolerate IV administration

Patients with history of skin reactions to heparin tolerate IV administration

Patients with an allergic inflammatory skin reaction to subcutaneous heparin generally tolerated IV administration of the medication, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

News
March 11, 2022
2 min read
Save

DOACs may prevent symptomatic VTE better than heparin after noncardiac surgery

DOACs may prevent symptomatic VTE better than heparin after noncardiac surgery

For prevention of venous thromboembolism after noncardiac surgery, direct oral anticoagulants may be preferred over low-molecular-weight heparin, according to a systematic review and meta-analysis.

News
October 28, 2021
3 min read
Save

Therapeutic-dose heparin lowers risk for VTE, death in hospitalized patients with COVID-19

Therapeutic-dose heparin lowers risk for VTE, death in hospitalized patients with COVID-19

Therapeutic-dose low-molecular-weight heparin decreased the likelihood of blood clots and death compared with standard of care among patients hospitalized with COVID-19, according to study results published in JAMA Internal Medicine.

News
September 03, 2021
1 min read
Save

Heparin-binding protein levels dramatically increase in acute pancreatitis

Patients with acute pancreatitis had significantly increased levels of heparin that were far greater than previously reported in other conditions, according to a study published in BMC Gastroenterology.

News
August 04, 2021
4 min read
Save

Therapeutic heparin may improve survival of noncritically ill patients with COVID-19

Therapeutic heparin may improve survival of noncritically ill patients with COVID-19

Therapeutic anticoagulation with heparin increased the likelihood of survival among noncritically ill patients who were hospitalized with COVID-19, according to a new study in The New England Journal of Medicine.

News
July 29, 2021
1 min read
Save

Top in hem/onc: Therapeutic heparin for COVID-19, TV viewing and VTE risk

Top in hem/onc: Therapeutic heparin for COVID-19, TV viewing and VTE risk

New research showed that hospitalized patients with COVID-19 who received therapeutic full-dose heparin were less likely to die than those who received prophylactic low-dose heparin. It was the top story in hematology/oncology last week.

News
July 20, 2021
3 min read
Save

Benefit of full-dose heparin for patients with COVID-19 warrants ‘new standard of care’

Benefit of full-dose heparin for patients with COVID-19 warrants ‘new standard of care’

Early administration of full-dose heparin slowed the thrombo-inflammatory process and reduced the risk for severe disease and death among moderately ill hospitalized patients with COVID-19, according to a study published in MedRxiv.

View more